|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
1998-2-5
|
|
pubmed:abstractText |
Liver disease has been described in 10%-15% of patients with autoimmune polyglandular syndrome type 1 (APS-1). After the discovery of cytochrome P450 1A2 (CYP1A2) as a hepatocellular autoantigen in liver-kidney microsomal autoantibody (LKM)-positive patients with APS-1, the investigation of antiliver antibodies was extended to 11 Sardinian patients with APS-1.
|
|
pubmed:commentsCorrections |
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
AIM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Feb
|
|
pubmed:issn |
0016-5085
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
114
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
324-8
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:9453493-Adult,
pubmed-meshheading:9453493-Aryl Hydrocarbon Hydroxylases,
pubmed-meshheading:9453493-Autoantibodies,
pubmed-meshheading:9453493-Autoantigens,
pubmed-meshheading:9453493-Blotting, Western,
pubmed-meshheading:9453493-Cytochrome P-450 CYP1A2,
pubmed-meshheading:9453493-Cytochrome P-450 Enzyme System,
pubmed-meshheading:9453493-Female,
pubmed-meshheading:9453493-Fluorescent Antibody Technique, Indirect,
pubmed-meshheading:9453493-Humans,
pubmed-meshheading:9453493-Male,
pubmed-meshheading:9453493-Mixed Function Oxygenases,
pubmed-meshheading:9453493-Pedigree,
pubmed-meshheading:9453493-Polyendocrinopathies, Autoimmune
|
|
pubmed:year |
1998
|
|
pubmed:articleTitle |
Two cytochromes P450 are major hepatocellular autoantigens in autoimmune polyglandular syndrome type 1.
|
|
pubmed:affiliation |
Istituto di Clinica e Biologia dell'età evolutiva, Università degli Studi di Cagliari, Italy.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
